140 related articles for article (PubMed ID: 34779502)
21. miR-30d suppresses proliferation and invasiveness of pancreatic cancer by targeting the SOX4/PI3K-AKT axis and predicts poor outcome.
Xu X; Zong K; Wang X; Dou D; Lv P; Zhang Z; Li H
Cell Death Dis; 2021 Apr; 12(4):350. PubMed ID: 33824274
[TBL] [Abstract][Full Text] [Related]
22. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
23. MiR-708-5p inhibits the progression of pancreatic ductal adenocarcinoma by targeting Sirt3.
Huang S; Guo H; Cao Y; Xiong J
Pathol Res Pract; 2019 Apr; 215(4):794-800. PubMed ID: 30683474
[TBL] [Abstract][Full Text] [Related]
24. Long non‑coding RNA PCED1B‑AS1 promotes pancreatic ductal adenocarcinoma progression by regulating the miR‑411‑3p/HIF‑1α axis.
Zhang Y; Ma H; Chen C
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036383
[TBL] [Abstract][Full Text] [Related]
25. lncRNA TINCR attenuates the proliferation and invasion, and enhances the apoptosis of cutaneous malignant melanoma cells by regulating the miR‑424‑5p/LATS1 axis.
Han X; Jia Y; Chen X; Sun C; Sun J
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34542165
[TBL] [Abstract][Full Text] [Related]
26. miR‑454‑3p suppresses cell migration and invasion by targeting CPEB1 in human glioblastoma.
Hui X; Zhang S; Wang Y
Mol Med Rep; 2018 Oct; 18(4):3965-3972. PubMed ID: 30106109
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
Yang Y; Tao X; Li CB; Wang CM
Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
[TBL] [Abstract][Full Text] [Related]
28. MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG.
An N; Zheng B
Technol Cancer Res Treat; 2020; 19():1533033819898729. PubMed ID: 32301392
[TBL] [Abstract][Full Text] [Related]
29. miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer.
Long M; Zhan M; Xu S; Yang R; Chen W; Zhang S; Shi Y; He Q; Mohan M; Liu Q; Wang J
Mol Cancer; 2017 Oct; 16(1):167. PubMed ID: 29078789
[TBL] [Abstract][Full Text] [Related]
30. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA hsa-miR-623 directly suppresses MMP1 and attenuates IL-8-induced metastasis in pancreatic cancer.
Chen Y; Peng S; Cen H; Lin Y; Huang C; Chen Y; Shan H; Su Y; Zeng L
Int J Oncol; 2019 Jul; 55(1):142-156. PubMed ID: 31115512
[TBL] [Abstract][Full Text] [Related]
32. MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3.
Zhao G; Zhang JG; Shi Y; Qin Q; Liu Y; Wang B; Tian K; Deng SC; Li X; Zhu S; Gong Q; Niu Y; Wang CY
PLoS One; 2013; 8(9):e73803. PubMed ID: 24040078
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of microRNA‑629‑5p in colorectal cancer and prevention of the malignant phenotype by direct targeting of low‑density lipoprotein receptor‑related protein 6.
Yan G; Li C; Zhao Y; Yue M; Wang L
Int J Mol Med; 2019 Sep; 44(3):1139-1150. PubMed ID: 31257454
[TBL] [Abstract][Full Text] [Related]
34. MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop.
Li T; Jian X; He H; Lai Q; Li X; Deng D; Liu T; Zhu J; Jiao H; Ye Y; Wang S; Yang M; Zheng L; Zhou W; Ding Y
J Exp Clin Cancer Res; 2018 Sep; 37(1):238. PubMed ID: 30253791
[TBL] [Abstract][Full Text] [Related]
35. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
36. MiR-299-3p inhibits proliferation and invasion of cervical cancer cell via targeting TCF4.
Yu Y; Zhao JD; Yang H
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5621-5627. PubMed ID: 31298314
[TBL] [Abstract][Full Text] [Related]
37. Linc00261 inhibits metastasis and the WNT signaling pathway of pancreatic cancer by regulating a miR‑552‑5p/FOXO3 axis.
Chen T; Lei S; Zeng Z; Zhang J; Xue Y; Sun Y; Lan J; Xu S; Mao D; Guo B
Oncol Rep; 2020 Mar; 43(3):930-942. PubMed ID: 32020223
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-495 inhibits the progression of non-small-cell lung cancer by targeting TCF4 and inactivating Wnt/β-catenin pathway.
Zheng HE; Wang G; Song J; Liu Y; Li YM; Du WP
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7750-7759. PubMed ID: 30536319
[TBL] [Abstract][Full Text] [Related]
39. MEF2C promotes gefitinib resistance in hepatic cancer cells through regulating MIG6 transcription.
Zhang H; Liu W; Wang Z; Meng L; Wang Y; Yan H; Li L
Tumori; 2018 Jun; 104(3):221-231. PubMed ID: 29714661
[TBL] [Abstract][Full Text] [Related]
40. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.
Gao W; Chen X; Chi W; Xue M
Int J Mol Med; 2020 Nov; 46(5):1743-1754. PubMed ID: 33000222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
